Maybe it’s comments like this that keep IPIX from moving...
“Global pharmaceutical companies have demonstrated a high demand, in deal size and volume, for novel oral IBD drugs—and our goal is to further validate Brilacidin in this space. First-in-human testing using the tablet form should help unlock the tremendous potential in Brilacidin for IBD."
Is Leo is still shopping it around? It seems almost impossible to believe that the BDD and Novartis Deal would be just a coincidence with the IPIX and BDD deal.
News 
Market Data 
Discover 
